A qualitative study sought to define themes related to patients’ symptoms and symptom management in the first year after prostate cancer treatment with curative intent.
News
A retrospective study evaluated the effect of adding nursing interventions to standard postoperative care on outcomes for patients with RCC.
Updated results from the phase 3 POUT trial support the use of adjuvant chemotherapy in patients with upper tract urothelial cancer, according to researchers.
There is no consensus on how hormone therapy impacts cognition in patients with prostate cancer, according to researchers.
Higher plant-based diet index linked to better scores for sexual function, urinary irritation/obstruction, urinary incontinence, hormonal/vitality.
Urinary incontinence persisted through 10 years after radical prostatectomy, however.
This study analyzed the cardiovascular effects of preoperative treatment with a chemotherapy and an immunotherapy in patients with bladder cancer.
Venous thromboembolism risks varied by cancer type and surgery.
Updated trial results suggest that lenvatinib and pembrolizumab can provide durable benefits over sunitinib in RCC.
Intensification of ADT prolonged PSA-PFS in patients with biochemically recurrent prostate cancer in a phase 3 trial.